· web viewsenegal work plan. fy 201. 7. project year . 6. october 201. 6 ‒ september 201....

SENEGAL Work PlanFY 2017Project Year 6

October 2016‒September 2017

ENVISION is a global project led by RTI International in partnership with CBM International, The Carter Center, Fred Hollows Foundation, Helen Keller International, IMA World Health, Light for the World, Sightsavers, and World Vision. ENVISION is funded by the US Agency for International Development under cooperative agreement No. AID-OAA-A-11-00048. The period of performance for ENVISION is September 30, 2011 through September 30, 2019.

The author’s views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government.

ENVISION PROJECT OVERVIEW

The U.S. Agency for International Development (USAID)’s ENVISION project (2011‒2019) is designed to support the vision of the World Health Organization (WHO) and its member states by targeting the control and elimination of seven neglected tropical diseases (NTDs), including lymphatic filariasis (LF), onchocerciasis (OV), schistosomiasis (SCH), three soil-transmitted helminths (STH; roundworm, whipworm, and hookworm), and trachoma. ENVISION’s goal is to strengthen NTD programming at the global and country levels and support Ministries of Health (MOHs) to achieve their NTD control and elimination goals.

At the global level, ENVISION—in close coordination and collaboration with WHO, USAID, and other stakeholders—contributes to several technical areas in support of global NTD control and elimination goals, including the following:

drug and diagnostics procurement where global donation programs are unavailable

capacity strengthening

management and implementation of ENVISION’s Technical Assistance Facility (TAF)

disease mapping

NTD policy and technical guideline development

NTD monitoring and evaluation (M&E).

At the country level, ENVISION provides support to national NTD programs by contributing strategic technical and financial assistance for a comprehensive package of NTD interventions, including the following:

strategic annual and multi-year planning

advocacy

social mobilization and health education

capacity strengthening

baseline disease mapping

preventive chemotherapy (PC) or mass drug administration (MDA)

drug and commodity supply management and procurement

program supervision

M&E, including disease-specific assessments (DSAs) and surveillance.

In Senegal, ENVISION project activities are implemented by RTI International.

ENVISION FY17 PY6 Senegal Work Plani

TABLE OF CONTENTSPage

ENVISION Project Overview.......................................................................................................................... i

List of Tables................................................................................................................................................ ii

Acronyms List.............................................................................................................................................. iii

Planned Activities........................................................................................................................................6

1) NTD Program Capacity Strengthening.............................................................................................6

a) Strategic Capacity Strengthening Approach................................................................................6

b) Capacity Strengthening Interventions.........................................................................................7

c) Monitoring Capacity Strengthening.............................................................................................7

2) Project Assistance............................................................................................................................7

a) Strategic Planning........................................................................................................................7

b) NTD Secretariat............................................................................................................................9

c) Advocacy......................................................................................................................................9

d) Social Mobilization.......................................................................................................................9

e) Training......................................................................................................................................15

f) Mass Drug Administration.........................................................................................................16

g) Drug and Commodity Supply Management and Procurement..................................................17

h) Supervision................................................................................................................................17

i) M&E...........................................................................................................................................19

3) Maps..............................................................................................................................................22

Appendix 1. SUMMARY OF ACTIVITIES......................................................................................................28

Appendix 2. Table of USAID-supported Regions and Districts...................................................................30

LIST OF TABLES

Table 1. Social mobilization/communication activities and materials checklist........................................12

Table 2. USAID-supported coverage results for FY16 and targets for FY17...............................................15

Table 3. Planned disease-specific assessments (DSAs) for FY17 by disease...............................................20

ENVISION FY17 PY6 Senegal Work Planii

ACRONYMS LIST

AE Adverse EventAFRO Africa Regional Office (WHO)ALB AlbendazoleAPOC African Programme for Onchocerciasis Control (WHO)ARG Africa Resource GroupASTMH American Society of Tropical Medicine & HygieneBREIPS Bureaux Régionaux de l’Éducation et de l’Information pour la Santé (Regional Offices for

Health Education and Information)CCA Circulating Cathodic AntigenCDC United States Centers for Disease Control and PreventionCDD Community Drug DistributorCDTI Community-Directed Treatment with IvermectinCM Case ManagementCODEC Collectifs des Directeurs d’École (School Principals’ Group)COR-NTD Coalition for Operational Research on NTDsCRS Catholic Relief ServicesCSR Corporate Social ResponsibilityCY Calendar YearDBS Dried Blood SpotDCMS Division du Contrôle Médical Scolaire (School Health Control Division) (MEN)DLM Direction de la Lutte contre la Maladie (Disease Control Directorate) (MSAS)DNA Deoxyribonucleic AcidDQA Data Quality AssessmentDSA Disease-Specific AssessmentECD Équipe Cadre de District (Health District Management Team)ECR Équipe Cadre de Région (Health Region Management Team)ELISA Enzyme-Linked Immunosorbent AssayENDA Santé Environnement et le Développement en Afrique-Santé (Environment and Development in

Africa-Health)EPIRF Epidemioogical Data Reporting FormFARA Fixed Amount Reimbursement Agreement (USAID)FTS Filariasis Test StripFY Fiscal YearGroupe ISSA Groupe Innovation et Système de Santé en Afrique (Innovation Group and Health System

in Africa)GTMP Global Trachoma Mapping ProjectHQ HeadquartersHRA High-Risk AdultHSS+ Health Systems Strengthening Plus (USAID)IA Inspection d’Académie (Schools Inspectorate)ICP Infirmier Chef de Poste (Health Post Head Nurse)ICT card Immunochromatographic Test CardIE Inspection de l’Éducation (Education Inspectorate)

ENVISION FY17 PY6 Senegal Work Planiii

IEC Information, Education, and CommunicationIEF Inspection de Formation et de l’Education (Training and Education Inspectorate)IME Inspection Médicale des Étudiants (Medical Inspectorate of Students)IR Intermediate ResultIST Inter-Country Support Team (WHO/AFRO)IT Information TechnologyITI International Trachoma InitiativeIVM IvermectinJRF Joint Reporting Form (WHO)JRSM Joint Request for Selected PC Medicines (WHO)LF Lymphatic FilariasisLOE Level of EffortM&E Monitoring and EvaluationMCD Médecin-Chef de District (Health District Head Doctor)MCR Médecin-Chef de Région (Health Region Head Doctor)MDA Mass Drug AdministrationMDP Mectizan® Donation ProgramMEB MebendazoleMEN Ministère de l’Education National (Ministry of National Education)Mf MicrofilaraemiaMHA Ministère de l’Hydraulique et de l’Assainissement (Ministry of Water and Sanitation)MOH Ministry of HealthMSAS Ministère de la Santè et de l’Action Sociale (Ministry of Health and Social Work)MSH Management Sciences for HealthNGO Nongovernmental OrganizationNTD Neglected Tropical DiseaseOMVS Organisation pour la Mise en Valeur du Fleuve Sénégal (Senegal River Development

Organization)OV OnchocerciasisPC Preventive Chemotherapy PCR Polymerase Chain ReactionPEPAM Programme d’Eau Potable et d’Assainissement du Millénaire (Millennium Potable Water

and Sanitation Program) (MHA)PGIRE Projet de Gestion Intégrée des Ressources en Eau et de Développement des Usages

Multiples du Bassin du Fleuve Sénégal (Integrated Water Resource Management Project) (OMVS)

PNA Pharmacie Nationale d’Approvisionnement (National Supply Pharmacy)PNEFL Programme National d’Élimination de la Filariose Lymphatique (National Lymphatic

Filariasis Elimination Program)PNLBG Programme National de Lutte contre la Bilharziose et les Géohelminthiases (National

Bilharzia and Soil-Transmitted Helminths Control Program)PNLO Programme National de Lutte contre l’Onchocercose (National Onchocerciasis Control

Program)PNLP Programme National de Lutte contre le Paludisme (National Malaria Control Program)PNPSO Programme National de Promotion de la Santé Oculaire (National Eye Health Promotion

Program)

ENVISION FY17 PY6 Senegal Work Planiv

PRA Pharmacie Régionale d’Approvisionnement (Regional Supply Pharmacy)PSSC II Programme Santé–Santé Communautaire II (Health Program-Community Health

component II) (USAID)PTA Plan de Travail Annuel (Annual Work Plan) (MSAS)PZQ PraziquantelR4D Results for Development InstituteRM Région Médicale (Medical Region)RPA Resident Program Advisor (RTI)RPRG Regional Programme Review Group (WHO/AFRO)SAC School-Aged ChildrenSAE Serious Adverse EventSAFE Surgery-Antibiotics-Facial Cleanliness-Environmental ImprovementSCH SchistosomiasisSIAPS Systems for Improved Access to Pharmaceuticals and ServicesSIM Subscriber Identity ModuleSMART Specific-Achievable-Measureable-Relevant-Time-BoundSNEIPS Service National de l’Education et de l’Information pour la Santé (National Health

Education and Information Service) (MSAS)SOP Standard Operating ProcedureSTAG Strategic and Technical Advisory GroupSTH Soil-Transmitted HelminthsTA Technical AssistanceTAF Technical Assistance FacilityTAP Trachoma Action PlanTAS Transmission Assessment SurveyTBD To Be DeterminedTEMF Trachoma Elimination Monitoring Form (WHO)TEO Tetracycline Eye OintmentTF Trachomatous Inflammation—FollicularTFGH Task Force for Global HealthTIPAC Tool for Integrated Planning and CostingTIS Trachoma Impact SurveyTSS Trachoma Surveillance SurveyTT Trachomatous TrichiasisUSAID United States Agency for International DevelopmentVAD Visite à Domicile (Home Visit)WASH Water, Sanitation, and HygieneWFP World Food ProgrammeWHO World Health OrganizationZTH Zithromax

ENVISION FY17 PY6 Senegal Work Planv

PLANNED ACTIVITIES

1) NTD Program Capacity Strengthening

a) Strategic Capacity Strengthening Approach

RTI will contribute to building the operating capacity and skills of Ministry of Health and Social Work (MSAS) Disease Control Directorate (DLM) NTD staff by continuing to participate in all of the DLM’s NTD meetings. RTI’s participation in these meetings constitutes an opportunity to communicate regularly with all of the DLM’s NTD personnel and to conduct personalized follow-up meetings with each DLM NTD staff member without formalities, enabling more efficient work in the short term and improving program performance in the long term.

RTI works closely with central-level MSAS NTD personnel to help them to develop and to lead the national NTD program’s long-term strategies and shorter-term activities.

RTI’s Regional Focal Points are embedded in the offices of the eight RMs outside of Dakar that ENVISION fully supports for integrated MDA; while reporting to their designated RTI supervisors in Dakar, they have effectively become an integral part of their respective RM’s Health Region Management Team [ECR]. This not only keeps the issue of NTDs on the RM’s radar year-round – rather than just during the MDA period as was previously the case – but it also provides a local source of NTD technical expertise, advocacy, and encouragement.

Strengthening of capacities for planning, monitoring, and evaluation: RTI staff will closely accompany the DLM’s NTD staff. The DLM’s NTD staff and RTI will jointly clean and finalize the DLM’s NTD PTA for 2017, establishing an action plan with a timeline and a checklist, and regular follow up.

RTI will help to ensure that the DLM’s NTD team receives copies of all key WHO guidelines, protocols, and recommendations. RTI will collaborate with the DLM’s NTD team to provide individual or group orientations on particular topics within those documents for members of this team.

In the RMs and health districts, the Regional Focal Points will use the quarterly meetings of the ECRs and the monthly meetings of the ECDs to raise issues related to PC-NTDs, ensuring that the MSAS teams and partners at these levels receives the latest technical information and guidance from the national NTD programs. Before, during, and after the MDA campaigns, the Regional Focal Points accompany and provide organizational and technical support to the RMs and health districts.

Strengthening knowledge of WHO guidance and protocols: Through close contact with the DLM via regular contact and meetings, RTI and the DLM will jointly identify the DLM’s needs in terms of technical orientation and/or training. RTI and the DLM will then jointly address these knowledge gaps or weaknesses through one-on-one or group orientations and/or training.

Provide copies of WHO reference documents related to NTD control: RTI ENVISION will financially support the ordering, printing, and/or photocopying of key WHO (and other) NTD reference documents and will share these with the DLM team after each knowledge-strengthening session (see preceding paragraph).

ENVISION FY17 PY6 Senegal Work Plan6

b) Capacity Strengthening Interventions

In general, strengthening the capacity of the DLM’s NTD personnel will also positively impact the RMs and health districts. All capacity building interventions conducted with the DLM will be shared with the regions and districts during the RMs’ quarterly coordination meetings, by the Regional Focal Points and/or by the DLM personnel who will periodically attend. The DLM will also share all technical and guidance documents with the regions and districts. In addition, RTI ENVISION’s Regional Focal Points will continue to technically and organizationally support the RMs’ NTD Focal Points.

c) Monitoring Capacity Strengthening

In FY17, RTI will assist the DLM in developing a timeline table (Gantt chart) listing all NTD-related coordination meetings. RTI will financially and technically support the DLM in holding these meetings as scheduled and will help the DLM track the participation of all NTD partners in these meetings. RTI will also assist the DLM in developing achievable, specific-achievable-measureable-relevant-time-bound (SMART)-type recommendations at the end of each coordination meeting, focusing on assigning responsibility for these recommendations to specific DLM personnel.

2) Project Assistance

a) Strategic Planning

Participation in the MSAS’s weekly NTD coordination meetings: RTI will regularly participate in these MSAS meetings, which are run by the DLM.

Funding of and participation in the MSAS’s quarterly NTD coordination meetings: RTI will fund and participate in this quarterly meeting run by the DLM. This meeting is held to monitor the progress of planned activities, discuss challenges, share information related to NTDs, and avoid duplication between partners. This includes collaboration with the water, sanitation, and hygiene (WASH) sector: the DLM has invited the Ministry of Water and Sanitation (Ministère de l’Hydraulique et de l’Assainissement [MHA]) to all of its meetings to date and named a Focal Point to participate in the MHA’s WASH sector coordination meetings.

RTI and DLM staff participation in the quarterly coordination meetings of the nine regional MSASs fully supported for integrated MDA: RTI will fund the participation of one DLM staff member in one general quarterly coordination meeting of each of the nine RMs fully supported by ENVISION for integrated MDA. RTI’s Regional Focal Points will participate in all such meetings that are held during the terms of their contracts. This presents an opportunity to focus on NTDs, including planned activities and their outcomes and results.

Participation in NTD partner coordination meetings: RTI will continue to advocate for and schedule meetings of the partners that support the MSAS’s national PC-NTD program. These meetings constitute an opportunity to discuss the activities implemented by each partner, identify opportunities for collaboration, and avoid duplication.

Updating and use of the TIPAC: The DLM will update the data in this tool in 2017 through monthly one-day work sessions with RTI ENVISION’s M&E and Capacity Building Officer. The updated version will be shared in the DLM’s quarterly NTD coordination meeting.


Support for the development of the MSAS’s annual NTD work plan (2018): Each year, for its DLM and national NTD programs, the MSAS organizes a workshop to develop a national PTA for NTDs in collaboration with its governmental and nongovernmental partners. RTI will fund this activity. Typically, participants separate into working groups on categories such as (1) coordination, (2) MDA and CM, (3) M&E, and (4) communication and WASH and then present their work to the plenary. Partners commit to supporting specific activities within the overall PTA as they are able. The compiled document is then finalized, validated, and shared with all participants. The workshop will last three days.

Trachoma mapping and impact survey debriefing: Cumulatively, from FY13 through FY16, the PNPSO is expected to complete trachoma baseline mapping in 17 districts, subdistrict-level mapping in 1 district, and one‒two trachoma impact surveys (TISs) in 14 districts, all with technical and financial support from ENVISION. Additional surveys are planned, also with ENVISION support, in FY17. It important to share these results and program successes with other parties involved in Senegal’s NTD program and the various communities concerned. RTI ENVISION will support the PNPSO in organizing a one-day debriefing meeting at the WHO/Senegal office to present and review the findings of these surveys (TF, TT, and WASH data) and Senegal’s new map of trachoma endemicity. This meeting will also serve as an opportunity to update the PNPSO’s roadmap for trachoma elimination, as established in the report from the MSAS’s Trachoma Action Plan (TAP) workshop. The MCDs of the districts where the surveys were conducted and the MCRs of their parent regions will be invited to participate.

OV elimination expert committee meeting: Senegal may be approaching the point at which it could stop MDA for OV. According to WHO’s 2016 OV elimination guidelines, before stopping MDA countrywide, a Ministry of Health (MOH) should establish an independent national oversight committee to address matters concerning OV elimination; this committee typically will include national and international experts and can be embedded in an existing national committee for NTD activities or OV-specific matters.1 This meeting will review the baseline prevalence, treatment history, epidemiological and entomological survey results, and various factors, such as cross-border endemicity, migration, and co-endemicity with LF. Based on the evidence, recommendations will be made for next steps toward OV elimination in this country. This two-day meeting will be held in Dakar, in the WHO/Senegal office if possible.

LF national technical review meeting: RTI ENVISION will technically and financially support this two-day workshop, which will be held in the WHO/Senegal office. Experts from WHO and RTI/HQ will help to facilitate. The meeting will address the status of LF in the country, review the implementation of the MSAS’s roadmap for elimination, and make recommendations for next steps, including planning for support for STH MDA as LF MDA reaches its stopping point over the coming years. Participants will include the DLM, RTI ENVISION/Senegal’s Dakar-based staff, MCRs from selected regions, and the MSAS’s technical and funding partners for LF, OV, STH, and malaria (in coordination with the PNLP) and WASH. This meeting will immediately follow the OV elimination expert committee meeting, allowing the relevant persons to easily participate in both meetings.

Trachoma elimination dossier development: RTI ENVISION will technically and financially support a three-day session bringing together the PNPSO, other members of the DLM, and partners supporting trachoma elimination in Senegal to review the various information and documents needed for the dossier and to compile those that are available at the time of the meeting (not all items will be available because different districts will be at different stages of elimination). The session will review the trachoma epidemiological situation, treatment history, roadmap, and recommendations from the TAP workshop held in December 2015. Beforehand, RTI will assist the DLM in pulling together the necessary 1 WHO. (2016). Guidelines for Stopping Mass Drug Administration and Verifying Elimination of Human Onchocerciasis: Criteria and Procedures, revised version. (pp. xiv and 22).


data from the country’s Integrated NTD Database. By the end of the session, the MSAS will have a preliminary version of the dossier and will know how to update it as the trachoma situation progresses. The session will be held in the WHO/Senegal office.

b) NTD Secretariat

Internet connectivity for the MSAS’s national NTD program: RTI ENVISION will improve the DLM and NTD program’s access to the Internet by paying for a subscription to a more reliable internet service provider and equipping the offices with appropriate routers; to ensure sufficient bandwidth, the access code will be shared with the DLM and NTD teams only.

Purchase of mobile phone SIM cards for the DLM’s NTD personnel: RTI ENVISION will add 10 SIM cards to its existing network of mobile phone numbers with TIGO, a mobile telephone service provider, for 10 DLM NTD staff (the DLM Director, one DLM secretary, the DLM Pharmacist, six PC-NTD Program Coordinators and/or assistants, and one financial/administrative manager). With these SIM cards, the DLM personnel will be able to call RTI personnel who are part of the same pool of TIGO phone numbers, at no cost. As part of the standard package, they will also receive limited air time each month to enable them to communicate with other NTD actors and partners. The DLM personnel will use these SIM cards in their existing personal mobile phones.

Financial support for vehicle maintenance: ENVISION will provide partial support for the cost of maintaining the MSAS vehicles used for national NTD program activities.

c) Advocacy

Support development and distribution of MSAS’s quarterly NTD newsletter: This activity will be supported by RTI working closely with central-level MSAS personnel. This activity will involve developing a template for written contributions to the newsletter and guidance for the submission of photos. Each quarter, RTI will meet for two days with three members of the MSAS’s NTD communications committee (one person each from the DLM, the SNEIPS, and the MEN’s DCMS), and with ENDA Santé, to compile, edit, review, and validate the final document. This newsletter will show the DLM’s current and upcoming NTD activities and will increase their visibility. It will be distributed to senior MSAS personnel, other ministries, the RMs, and the MSAS’s technical and funding partners. The document will be a maximum of seven pages and include color illustrations, text, and photos.

d) Social Mobilization

NTD communications committee: RTI will collaborate with other members of the NTD communications committee (the DLM and SNEIPS) in charge of IEC/behavior change communication for PC-NTDs in 2017. This committee will also collaborate with the BREIPS, which are extensions of the SNEIPS in the RMs. The committee will be responsible for the following:

developing an NTD communications plan for 2017 focused on MDA and other NTD control activities

organizing an NTD information day for journalists, the SNEIPS’s “numéro vert” free public-health information phone line staff, and BREIPS staff

developing NTD-related event trailers for radio and TV, for example, about the MDA launch day and the MDA period


developing NTD-related publicity spots for radio and TV

organizing the broadcasting of radio and TV spots

designing NTD-related communications for the internet (posting ads on Senegal’s most-visited website, Seneweb, each day during the month of the MDA campaign)

producing and distributing IEC materials.

The messages used in the spots and posters were initially developed in 2014 in a three-day workshop jointly organized by PSSC II and the SNEIPS, involving communications specialists. These messages were tested in the community, under the SNEIPS, then adapted and validated in another workshop before production. After the 2014 MDA campaign, regions and districts gave feedback on the posters, which was then incorporated in revised versions of the posters. After the 2015 campaign, regions and districts gave feedback on the posters and on the TV ads; these suggestions were incorporated into revised versions of posters and TV ads produced for the 2016 campaign.

Production of IEC materials: All IEC materials were developed as part of MDA preparatory activities in FY16. For FY17, only the production of these materials will be needed. These materials will include posters, banners, t-shirts, baseball-type caps, and collared t-shirts for the supervisors. These materials will be provided to the central level (MSAS, SNEIPS, and MEN) and to the nine RMs that will be supported by ENVISION for integrated MDA. The materials will be transported to and distributed in those nine regions one month before the start of the MDA campaign.

Design and broadcasting of trailers, commercials, and shows on radio and TV: With support from RTI (which is a committee member), the NTD communications committee will ensure the technical accuracy, appropriateness, and clarity of messages for the general population. Broadcasts will occur at appropriate times to reach the target populations and via broadcasters with national coverage and high viewer- or listenership. The DLM and the SNEIPS will moderate health-focused radio and TV shows to raise the public’s awareness of NTD control and inform them of the strategies used by the MSAS. The committee will also design live shows involving well-known performers to be broadcasted in Wolof and French on the appropriate channels or networks and at appropriate times to reach a wide swath of the public.

The national broadcasts have wide reach but are not as linguistically diversified as more local broadcasts, which have their own viewer- and listenership. In the regions and districts where MDA will be conducted, there are community radio and TV stations that broadcast in local languages. The NTD communications committee will provide the finished communications products (e.g., radio and TV commercials and trailers) to the RM teams, which consist of the RM’s NTD Focal Points, the BREIPS, and RTI’s Regional Focal Points. These teams will be responsible for working with the local media to translate the commercials into local languages and to collaborate with the health districts to sign contracts for broadcasting the commercials on community radio.

At all levels, airing of the messages should begin well before the start of the MDA campaign (at least one month before the campaign at the national level and at least 15 days beforehand at the regional and district levels).

Organization of a national MDA launch day: RTI ENVISION will financially and organizationally support the DLM in organizing this activity two days before the start of integrated MDA with the participation of senior health and education authorities. The launch day will strengthen the ownership of NTD control by all actors in the health system and the commitment of all stakeholders. The launch will also be broadcasted on national TV to raise awareness and gain the adherence of the general public.


Community mobilization strategy: This will consist of systematically involving all influential community groups in the organization of NTD control activities. The strategy will be focused on informing the public about the MDA strategy via the appropriate communications channels, messages, and use of IEC materials. The intent is to secure the targeted populations’ acceptance of and adherence to the MDA. This community mobilization will be done at RM and health district levels and will be organized by the BREIPS supported by the RM’s NTD Focal Point and RTI’s Regional Focal Point. The following activities to mobilize influential groups will be organized starting between one month and 15 days before the start of the MDA:

Community advocacy: This targets local and administrative authorities and community leaders, encouraging them to share information on the strategy and negotiating their active participation in the different phases of activity implementation. Advocacy will be led by the ECRs, ECDs, and ICPs.

Information caravans: These will be organized within each zone of responsibility of the RM for more active, personal communication and to mobilize the general public. The community relays supported by the ICPs will post posters in public meeting places and will conduct home visits to inform community leaders and their families. Discussion topics will include the magnitude of NTDs in Senegal, preventive behaviors (face washing, draining of ponds,2 avoiding consumption of soil/dirt, using impregnated bed nets, and wearing shoes), diagnostics (what are the telltale symptoms), and the benefits of MDA against NTDs.

Partnership with schools and daaras (Koranic schools): This will consist of using the teachers/Koranic teachers and students/talibés as potential relays to inform other students/talibés and community members about the MDA campaign. Educational and recreational activities will be organized in the form of life lessons and/or skits.

Partnership with sporting and cultural associations (association sportive et culturelle) and community-based organizations: The actors will be integrated into the information caravans.

Radio commercials and shows: This strategy will be led by the central level through the national media. The broadcasting of shows and commercials will also be negotiated with community radio stations in the nine regions supported by ENVISION for MDA.

2 If this is not done, children must avoid bathing in or drinking the pond water.


Table 1. Social mobilization/communication activities and materials checklist

Category Key messages Target population IEC strategy

Where/when will they be distributed?

FrequencyIndicator/mechanism

to track this material/activity

MDA participation (this is the principal intent of all of these social mobilization messages)

La lutte contre les MTN une affaire de Tous (The fight against NTDs is everyone’s business)

General public

- T-shirts- collar t-shirts- banners- radio and TV

commercials- awareness-

raising caravan

- in ENVISION-supported RMs

- starting one month to 15 days before the start of MDA

Continuously throughout the MDA campaign period

Number of actors equipped with material(s)/number of actors planned

Profitons du traitement de masse une opportunité de prévention et de traitement contre les MTN (Mass treatment is an opportunity for the prevention and treatment of NTDs)

General public

- T-shirts - radio and TV

commercials- awareness-

raising caravan




Number of actors equipped with material(s)/number of actors planned

La campagne de masse une opportunité de prévention et de traitement (The mass campaign is an opportunity for the prevention and treatment of NTDs).

Above the message, there is the following phrase:Lutte contre les Schistosomiases (Fight against SCH)

General public

- radio and TV commercials

- home visits (Visite à Domicile [VAD])

- SCH poster




Number of posters used/number of posters received

Profitons de cette campagne de masse pour prévenir la filariose

General public


- VAD


Continuously throughout the MDA







lymphatique et ses complications (Let’s benefit from the mass campaign to avoid LF and its complications)

- LF poster - starting one month to 15 days before the start of MDA

campaign period

La campagne de masse offre une opportunité pour se déparasiter et rester en bonne santé (The mass campaign is an opportunity to deworm and stay in good health)

General public


- VAD- STH poster





Le trachome est une maladie qui peut faire perdre la vue. Profitons de cette campagne de masse pour lutter contre cette maladie (Trachoma is a disease that can cause loss of sight; let’s benefit from this mass campaign to fight this disease)

General public


- VAD- trachoma poster





L’onchocercose est une maladie qui peut faire perdre la vue. La campagne de masse prévient cette complication (OV is a disease that can cause loss of sight. The mass campaign prevents this complication.)

General public


- VAD- OV poster





La campagne de DMM contre les MTN permet d’éviter la survenue

General public


- VAD


Continuously throughout the MDA







d’hydrocéle, de lymphoedéme, d’ascite, d’hématurie et de cécité (The MDA campaign against NTDs makes it possible to avoid the occurrence of hydrocele, lymphodema, ascites, hematuria, and blindness)

- PC-NTD complications poster


campaign period

Les médicaments contre les MTN à CTP existent et sont distribués gratuitement lors des DMM (Drugs against PC-NTDs exist and are distributed free of charge during MDA)

General public

Radio and TV - by all contracted stations and networks

- starting one month to 15 days before start of MDA

Three‒four airings or broadcasts per week until the end of the MDA campaign

Number of broadcasts aired/number of broadcasts planned

Les MTN limitent le développement socio-économique du pays (NTDs limit the country’s socioeconomic development)

General public

Radio and TV - by all contracted stations and networks


Three‒four airings or broadcasts per week, until the end of the MDA campaign

Number of broadcasts aired/number of broadcasts planned


e) Training

Training of the ECDs on finance mechanisms: To harmonize and facilitate the implementation of funding of MDA in FY17, RTI ENVISION will technically and financially support the DLM in training the ECDs on finance mechanism, with one three-day training session in each of the nine RMs that are receiving direct funding from RTI ENVISION. Each region’s training will bring together all of the health districts in that region, with three people from each health district (MCD, NTD Focal Point, and financial/administrative officer). The trainings will be jointly led by one RTI staff member and one DLM staff member, with the participation of three personnel from the RM (MCR, NTD Focal Point, and financial/administrative officer) plus the ENVISION Regional Focal Point. The training will focus on the basic principles of the finance mechanisms, the funding allocation process, the agreements, the payment deadlines, reporting, and other responsibilities. The trainings will also provide an opportunity to establish budget estimates for each supported health district for the FY17 MDA campaign.

NTD refresher-training for journalists, the SNEIPS’s “numéro vert” staff, and BREIPS staff in ENVISION-supported regions: RTI ENVISION will technically and financially support the DLM’s two-day orientation on NTDs and the MDA campaign for approximately 40 journalists, 20 staff members of the SNEIPS’s “numéro vert” free public-health information phone line, and nine staff members from the BREIPS of ENVISION-supported regions, one month before the start of the MDA campaign. The national NTD Program Coordinators will give up-to-date presentations, answer questions, and provide informational documents. This activity will increase the visibility of the MSAS’s national NTD program and the MDA campaign through improved understanding of and increased interest in these topics by the trainees (who have influence with the public through their public communications roles) and more directly through the articles and reports that will be produced as a result. Because these journalists play a key role in informing public opinion, it is important for them to have a good understanding of the disease and the rationale and benefits of the control activities conducted by the national program and its partners.

Cascade refresher training for ECRs, ECDs, ICPs, and drug distributors: A one-day orientation and refresher-training3 focusing on the PC-NTDs targeted in each specific district will be incorporated into the micro-planning workshops for the FY17 MDA campaign, first in the RMs and then in the health districts. These sessions will take into account the recommendations and lessons learned from the 2016 MDA campaign and will occur at each of the following levels:

region: orientation of the ECRs (45) and IAs (9)

district: orientation of the ECDs (260) and the IEFs’ (49) NTD Focal Points

periphery: orientation of the ICPs and the school principals’ group (Collectifs des Directeurs d’École [CODEC])

(refresher) training of teachers from public schools and daaras (Koranic schools) and CDDs.

The DLM team will conduct orientations for each of the nine supported regions’ ECR, ECD, IA, and IEF personnel in their respective regional capitals. These trainees will constitute the pool of trainers for their region and will be responsible for training the ICPs and CODECs. Once the ICPs and CODECs are trained, they will, in turn, train the teachers and CDDs (who are also responsible for raising awareness in the community).3 Orientation: adaptation of certain practices and changes in certain strategies. The ECRs and ECDs are oriented to enable them to train or provide refresher training to the personnel they supervise.Refresher training: reminder of skills and knowledge for people who have already been trained.


The education sector plays a key role in MDA for the target population in the schools. The public school and daara teachers teach life-skills lessons on NTDs and MDA to strengthen their students’ knowledge, and in turn, the students serve as relays in their communities.

Considering the request made by teachers for a drug distributor’s manual, which was a strong recommendation from the national MDA data validation workshop in May 2016, and the intention to increase the number of CDDs for the 2017 round of MDA, RTI ENVISION will print copies of this document, both for the new trainees and for prior participants who may need a replacement copy.

f) Mass Drug Administration

Dose poles for MDA: ENVISION will procure flexible-fabric dose poles for PZQ+IVM and for ZTH tabs+powder for oral suspension. This type of dose pole is durable, takes up little space, and is easy to carry. These poles will principally be made available to teachers, who did not receive them in sufficient quantities in FY16, and will complement the supply remaining (principally at the community level) from last year.

Regional MDA data validation meetings: ENVISION will technically and financially support the nine fully supported RMs, three districts of Louga Region, and one district of Saint Louis Region (the latter for trachoma MDA) in conducting meetings to review and validate their MDA results and data.

National MDA data validation meeting: ENVISION will technically and financially support the DLM in conducting a meeting to review and validate MDA results and data from the national MDA campaign.

Table 2. USAID-supported coverage results for FY16 and targets for FY17

NTD# of rounds of

annual distribution

Treatment target (FY16)

# of districts

# of districts not meeting epi coverage

target in (FY16)

# of districts not meeting

program coverage

target (FY16)

# of treatment-

targeted persons (FY16)

# of treated persons (FY16)a

% of treatment

target met(FY16)

(persons)b

# of districts targeted

for treatment

(FY17)

# of persons targeted

for treatment

(FY17)LF 1 33 0 5,347,179 4,975,698 93.11% 33 5,532,740OV 1 1 0 80,467 75,234 93.50% 1 250,552SCH 1 9 1 318,267 305,406 95.96% 13 641,875STH 1 76 0 3,264,628 3,746,118 114.75% 52 3,358,129TRA

1 8

Zero as of early July

2016; TBD for the remaining

four, which will be treated

in late July 2016

1,136,187 738,303c 64.98%d

Between 2 and 10, depending on the results of eight TISs that are

ongoing in FY16

TBD based on the

results of surveys

performed in FY16

aAs of early July 2016.bCalculated for districts treated, and drug packages administered through early July 2016 (i.e., treatments that are scheduled for later in FY16 are not included in the calculation). This table includes the results for all integrated MDA campaigns (LF, OV, SCH, and STH) that were planned for the entire FY but just four of the eight districts targeted for trachoma MDA; the final four districts are scheduled to conduct MDA in late July 2016, and thus, the results are not available at this time.cThis figure includes results for four districts: Bambey (Diourbel Region) and Khombole, Mékhé, and Tivaouane (Thiès Region). The other four districts—Diourbel (Diourbel Region), Gossas (Fatick Region), and Coki and Sakal (Louga Region)—will conduct their MDA in late July 2016.d This percentage is based on the results for the four districts—Bambey (Diourbel Region) and Khombole, Mékhé, and Tivaouane (Thiès Region)—that completed their treatment by early July 2016. The total percentage will increase once the results are


available for the other four districts—Diourbel (Diourbel Region), Gossas (Fatick Region), and Coki and Sakal (Louga Region)—which will conduct their MDA in late July-early August 2016.

g) Drug and Commodity Supply Management and Procurement

Procure TEO for trachoma MDA and impact and surveillance surveys: In trachoma-endemic districts of Senegal, children aged under 6 months and pregnant women are treated with TEO during trachoma MDA; each individual is given two tubes. During surveys, individuals displaying active trachoma are provided with two tubes.

Procure Kato-Katz kits for SCH (and STH) prevalence evaluation surveys: The quantity of Kato-Katz kits required is calculated on the basis of 50 SAC per site, with 5 sites per district or ecological zone. The MSAS has a plan for case-management of drug-related adverse events during MDA, with a clear decision flow-chart. Any suspected adverse event at community level is referred to the health post, where notification forms are completed and sent directly to the central-level MSAS (anti-poison center, with copy to the DLM). The DLM’s NTD pharmacist closely follows this entire process during the campaign period.

h) Supervision

Supervision of the regional micro-planning workshops: Prior to the MDA campaign, the ECRs will organize a one-day workshop for training and micro-planning involving the ECDs, IEF, CODEC, and partners to remind all parties of the goals of the campaign, define treatment strategies, share lessons learnt from FY16 with actors and partners, and allocate materials and financial resources by health district. RTI will support the DLM in conducting this activity in the nine ENVISION-supported regions (through its Regional Focal Points) and in the three supported districts of Louga Region and one supported district of Saint Louis Region.

Supervision of the district micro-planning workshops: With facilitation by its MCD and NTD Focal Point, each district will organize a one-day training and micro-planning workshop involving the ICPs and CODECs to prepare the MDA campaign. RTI will support this activity in the nine ENVISION-supported regions and the three supported districts of Louga Region and one supported district of Saint Louis Region.

Supervision of MDA: At the MSAS’s request, RTI will join the central-level MSAS teams in supervising the MDA campaign in the nine RMs, three districts of Louga Region, and one district of Saint Louis Region in which ENVISION will be supporting MDA. Each region will be logistically and technically supported by two supervisors from the central level. Additionally, each supervisory team will ensure the quality of drug distribution and assist in awareness-raising, data quality control, and data compilation. ENVISION will fund the cost of the supervision by the central-level MSAS and for the nine supported RMs, three supported districts of Louga Region, and one supported district of Saint Louis Region.

Integrated MDA (and, later, trachoma MDA as needed) will occur over the same six-day period in all targeted areas of the country. Each region will be logistically and technically supported by two supervisors from the central level. Each supervisory team will ensure the quality of drug distribution and assist in awareness-raising, data quality control, and data compilation. The supervisory teams will be equipped with supervision tools to assess the quality and completeness of data, the archiving system, and the knowledge level among the health personnel. At the community level, the CDDs will be supervised by the community supervisors (where present) and/or the ICPs, and the teachers will be supervised by the ICPs. The CDDs should be supervised at least once a day by personnel from the health post, the health district personnel, the RM, or the central level. This supervision will consist of reviewing


the completion of the data management tools, the completeness and quality of the data, and the CDDs’ knowledge of NTDs.

The DLM and RTI staff will supervise the orientation sessions for ECR and ECD teams prior to the MDA campaigns using the supervisory modules presented in those sessions. DLM personnel, equipped with supervision grids, will supervise MDA implementation and the data entered into the templates and reports from the campaign. In some districts organizing MDA with ENVISION support, the ECDs will conduct convenience surveys—rapid, simple surveys used to understand the progress of activities, MDA drug-taking, the number of people treated, and/or the number of people who should be treated—in approximately 10 households per district to help ensure that the key points of the MDA campaign were respected.

The DQA tool can be simplified and used by supervisors to monitor MDA activities, particularly the data quality, drug distributors’ knowledge levels, and the availability of data collection and management tools.

Supervision of M&E: RTI will assist the MSAS by jointly supervising M&E-related activities, including the rollout and/or implementation of key monitoring tools, such as the Integrated NTD Database, TIPAC, and USAID M&E Workbooks, and conducting surveys to aid in programmatic decision-making. RTI will also assist the MSAS by reviewing survey and assessment protocols to ensure that they will provide the information needed and that they are in line with WHO guidance. The DLM and RTI will jointly supervise the surveys to ensure that data entry technicians and surveyors are following the protocol and filling out the survey forms correctly.

RTI will help the MSAS ensure that WHO guidance is respected and that the MSAS’s strategies, as established in its Master Plan, are followed. Starting in FY17 Q1, in the lead-up to the MDA campaign, the organizers will meet regularly. In the weekly meetings organized by the DLM, RTI will raise topics related to WHO guidance, such as the use of the DQA tool and TAS for LF. These meetings will constitute an opportunity to discuss the strategies recommended by WHO and programmatic decision-making for the years to come.

RTI will also ensure that the MSAS’s PC-NTD Coordinators are equipped with WHO guidance documents related to the five PC-NTDs, as appropriate. If WHO/Senegal does not have these materials, RTI can provide them in electronic and/or print form.

The two MSAS NTD committees (Technical and Communications) are composed of DLM personnel and partners, including WHO. These committees will meet once a week and initiate preparatory activities for the MDA campaign, thereby enabling the national NTD program to reach its goals for MDA treatment coverage. The DLM will contact the ECRs and ECDs of the targeted regions and districts to prepare for the integrated MDA campaign scheduled for March-May 2017.

The following activities will help to identify and address issues and/or bottlenecks that arise during the course of the MDA campaign:

Participation in preparatory activities for the MDA campaign: RTI will support the DLM with weekly work sessions of the MSAS’s NTD Technical Committee and Communications Committee to jointly plan the MDA campaign.

Monitoring of the implementation of the MDA communications plan: RTI will collaborate with the DLM to ensure that the populations of all ENVISION-supported targeted districts are sufficiently aware of the MDA campaign by supporting the ECDs in organizing convenience surveys in each district just before the start of the campaign.


Close supervision of MDA drug distributors (teachers and volunteers): Central-, regional-, and district-level MSAS supervisors will supervise the drug distribution teams using the MDA supervision tool to assess the distribution technique, the quality of the data collected, the management of MDA drugs, and the distributors’ knowledge levels. This supervision will allow for issues to be corrected while the campaign is still ongoing.

Daily data reporting: The ICPs will be responsible for reporting their MDA data to the health districts each day of the campaign and for calculating their coverage and changing strategy as needed to reach the goals. The supervisory teams will support the ICPs to ensure that daily monitoring of treatment coverage is effective at all levels.

Returning unused MDA drugs: The DLM and RTI staff will sensitize the ECRs and ECDs on the importance of returning unused MDA drugs to the PRAs immediately following the MDA campaign.

Informing certain schools of the MDA campaign: In collaboration with the DLM, RTI will strive to ensure that the MEN’s letter to school inspectors regarding the MDA campaign reaches the school inspectors in time. On the eve of the campaign, the DLM should call each of the MEN’s regional IAs to ensure they have received the message.

Close coordination with other campaigns: The DLM will coordinate with other MSAS programs to avoid overlap in activities, where possible, and will set an optimal date for the MDA campaign.

Ensuring that administrative authorities are involved: On the eve of the MDA campaign, the MCRs and regional governors should convene the Regional Development Committee, and the municipal prefects should convene the Departmental Development Committee to help ensure that all local and administrative authorities are aware of the campaign.

Please see the M&E section below for an explanation of M&E activities in support of the MDA campaign, i.e., the DQA.

i) M&E

Support for the preparation of the WHO Joint Application Matrix (JRSM, JRF, and EPIRF): In collaboration with RTI, WHO will orient the MSAS’s NTD Program Coordinators on the completion of these tools in advance of their submission in a one-day meeting in either the WHO/Senegal or RTI ENVISION Senegal office. After the meeting, RTI will assist the MSAS in completing and submitting these documents if the MSAS is willing to accept this support.

Updating the Integrated NTD Database: RTI and the DLM’s Data Manager will meet monthly to update the Database with data on interventions and surveys. The DLM will generate reports using the Database and share these with WHO.

Data Quality Assessment: The DLM and RTI will jointly organize a DQA, using the standard WHO/ENVISION DQA tool, one month after the integrated MDA campaign. The DQA, which will be led by two DLM personnel and two RTI personnel, will facilitate understanding the quality of reported MDA data and the reporting systems, thereby allowing the coherence of the data submitted upward through the system and presented at the national MDA data validation meeting to be assessed.

Trachoma impact surveys in six districts: RTI will technically and financially support the PNPSO in conducting TIS in six districts, with implementation by PNPSO personnel under the supervision of the PNPSO Director and RTI. This activity will include the following:


three districts (Gossas, Coki, and Sakal) that will complete their third and final round of trachoma MDA in FY16

one district (Diourbel) that conducted a first impact survey in FY15 showing 5%‒9.9% TF and that will conduct an additional round of MDA in FY16

two of the eight districts that registered 5%‒9.9% TF in baseline mapping more than three years’ prior (Joal-Fadhiouth in 2004; Mbour, Popenguine, and Thiadiaye in 2005; Louga in 2010; Guinguineo and Dahra in 2011; and Passy in 2013) and have not initiated MDA. Given the possibility that conditions in these districts may have changed since the time of mapping, the PNPSO wishes to reassess the prevalence in these districts to confidently determine which interventions are required.

Those districts that register <5% TF may stop MDA (or not initiate MDA in the first place), and those that register 5%‒9.9% TF should conduct a follow-up round of MDA, followed by a second TIS.

As previously, the impact surveys will follow the standard WHO protocol and use Android smartphones and WHO’s Tropical Data system for data collection. The teams will (1) survey the prevalence of TF among children aged one‒nine years, (2) survey the prevalence of TT among men and women aged ≥15 years (including the presence or absence of corneal opacities among all persons examined for TT), and (3) measure links between trachoma and environmental and behavioral factors (e.g., availability and use of latrines, facial cleanliness, household cleanliness, and access to water). Supplementary training is not required as the current qualified survey teams will conduct these surveys.

Trachoma surveillance survey in one district: RTI will technically and financially support the PNPSO in conducting a TSS in one district, with implementation by PNPSO personnel under the supervision of the PNPSO Director and RTI. Kébémer District, which registered 4.7% TF (and 1.1% trichiasis among adults) in its ENVISION-supported TIS in FY14, allowing it to stop MDA, will conduct its TSS the stipulated 24 months after the TIS, in line with ITI recommendations.4 According to WHO interim recommendations, the surveillance survey should be conducted as a district-level cluster random sample, two years after a district-level impact assessment showed that the elimination targets for both TF (<5% in one‒nine year olds) and TT (<0.2% in adults) have been reached.5 The existing teams of qualified trachoma graders and data recorders will conduct the survey using Android smartphones and the Tropical Data System. If the results show ≥5% TF, MDA should be resumed, whereas if the results indicate <5% TF, MDA is not indicated. The trachoma elimination dossier can be finalized once all districts achieve the elimination targets for TF and TT. Supplementary training is not required as the current qualified survey teams will conduct this survey.

SCH-STH prevalence evaluation surveys in eight districts: The eight districts (Dioffior, Foundiougne, Birkelane, Joal-Fadhiouth, Thiadiaye, Diouloulou, Thionk Esyl, and Ziguinchor) that have conducted five‒six rounds of MDA with PZQ and have not yet performed prevalence evaluation surveys for SCH and STH will do so in FY17, in line with WHO guidance and with technical and financial support from RTI ENVISION. This survey should occur in February 2017 to include districts that are slated to continue their SCH-STH MDA in March‒April 2017. This is in line with the PNLBG’s strategy, and WHO guidance, to conduct prevalence evaluation surveys in qualifying districts each year as appropriate, for the purpose of decision-making about treatment frequency. The results will enable the MSAS to decide whether to maintain or adjust the treatment schedule for these districts, in line with WHO guidance based on prevalence (>50%: once per year, 10%‒50%: once every two years, and 1%‒<10%: once every three years).

4 ITI. (2015). Diagram on Decision Making for Antibiotic Treatment of Trachoma, version 9.5 WHO STAG on NTDs. (2014). Proceedings from the Technical Consultation on Trachoma Surveillance.


The goal of the survey is to assess the prevalence values and intensities of urinary and intestinal SCH and of STH in the identified sentinel sites. The following techniques will be used to examine stool and urine samples: a) macroscopic examination of urine, b) use of reagent strips for urine, c) microscopic examination of urine filter for Schistosoma haematobium eggs (one slide per child), d) Kato-Katz with microscopic examination of fecal material for Schistosoma mansoni and STH eggs in stool samples (two slides will be examined per child), and e) CCA rapid tests for urine. Each of the six data recorders will capture the survey data using the PEAR application on Android smartphones, enabling the identification of the global positioning system position and daily uploading of data to a server where they can be cleaned in real time.

Supplementary training is not required as the current qualified survey teams will conduct these surveys.

Table 3. Planned disease-specific assessments (DSAs) for FY17 by disease

Disease No. of districts planned for DSA Type of assessment Diagnostic method

SCH-STH 8a Prevalence evaluation survey

Kato-Katz, dipsticks, urine filtration, and CCA

Trachoma6 Impact survey Clinical grading

1 Surveillance survey Clinical gradingaDistricts that have completed at least five rounds of PZQ MDA but have not conducted a prevalence evaluation survey.


3) Maps


APPENDIX 1. SUMMARY OF ACTIVITIES

FY17 Activities

Capacity Strengthening StrategyOngoing TA to the MSAS’s NTD programs Strengthen capacity for planning, monitoring, and evaluationStrengthen knowledge of WHO guidance and protocolsProvide copies of WHO reference documents related to NTD controlProject AssistanceStrategic PlanningParticipation in the MSAS’s weekly NTD coordination meetingsFunding of and participation in the MSAS’s quarterly NTD coordination meetingsParticipation by RTI and DLM staff in the quarterly coordination meetings of the nine regional MSASs fully supported for integrated MDAENVISION Senegal team quarterly coordination meetingsParticipation in NTD partner coordination meetingsFunding of and participation in development of the MSAS’s annual NTD work plan (2018)Debriefing on trachoma mapping and impact survey resultsOV elimination expert committee meetingLF national technical review meetingTrachoma elimination dossier developmentNTD SecretariatInternet connectivity for the MSAS’s national NTD programPurchase of mobile phone SIM cards for the DLM’s NTD personnelFinancial support for vehicle maintenanceBuilding Advocacy for Sustainable National NTD ProgramPresentation of ENVISION FY17 work plan at central and regional levelsSupport development and distribution of MSAS’s quarterly NTD newsletterMonthly meeting with the MSAS’s DLM DirectorSocial Mobilization to Enable NTD Program ActivitiesNTD communications committeePublic gatherings and outreach in the communityOrganization of a national MDA launch dayProduce IEC materialsDesign, broadcasting, and posting of trailers, commercials, shows, announcements, and notices on radio, TV, internet, and newspapersTrainingTraining of the ECD teams on the FOGsNTD refresher-training for journalists, the SNEIPS’s “numéro vert” staff, and BREIPS staff in ENVISION-supported regionsCascade refresher training for ECRs, ECDs, ICPs, and drug distributors (within the 53 supported districts)Refresher training of RTI ENVISION’s Regional Focal PointsDrug supply management and procurementProcure TEO for trachoma MDA and surveysProcure Kato-Katz kits for SCH-STH prevalence evaluation surveysDrug distributionMDA preparationMDA implementationSupervision


FY17 Activities

Supervision of trachoma impact and surveillance surveysSupervision of SCH-STH prevalence evaluation surveysSupervision of the regional micro-planning workshopsSupervision of the district micro-planning workshopsSupervision of MDAM&ESCH-STH prevalence evaluation surveys in eight districtsTrachoma impact surveys in six districtsTrachoma surveillance survey in one districtData quality assessmentNational and regional MDA data validation workshops (at central level and in the 11 regions supported for MDA)Update Integrated NTD Database


APPENDIX 2. TABLE OF USAID-SUPPORTED REGIONS AND DISTRICTS

Region Health districts MDA (drug packages)a

SCH-STH prevalence evaluation

survey

Trachoma impact survey

Trachoma surveillance

survey

Dakar

Sud ALB Centre ALBOuest ALBNord ALBGuédiawaye ALBPikine ALBKeur Massar ALBMbao ALBDiamniadio ALBRufisque ALB

Diourbel

Bambey

IVM+ALB+PZQ

Pending, based on FY16 mapping results: ZTH+TEO

Diourbel PZQ+ALB XMbacké IVM+ALB

Touba

IVM+ALB


Fatick

Niakhar IVM+ALB+PZQFatick IVM+ALB+PZQDioffior IVM+ALB XPassy PZQ+ALB Xb

Foundiougne ALB XSokone IVM+ALBGossas IVM+ALB+PZQ X

Kaffrine

Birkelane

IVM+ALB


X

Kaffrine

IVM+ALB+PZQ


Koungheul

IVM+ALB+PZQ


Malem Hodar

IVM+ALB+PZQ


Kaolack

Guinguineo IVM+ALB Xb

Kaolack IVM+ALBNdoffane PZQ+ALBNioro ALB




survey



survey

KédougouKédougou

(OMVS/PGIRE)SalémataSaraya

Kolda

Kolda IVM+ALBMédina Yoro Foulah

IVM+ALB

Vélingara IVM+ALB

Louga

Darou Mousty ALBKébémer ALB XLinguère (OMVS/PGIRE)Dahra ALB Xb

Coki

(OMVS/PGIRE)

XKeur Momar SarrSakal XLouga Xb

Matam

Kanel

(OMVS/PGIRE)MatamThilogneRanérou

Saint Louis

Dagana(OMVS/PGIRE for IVM+ALB+PZQ)

ZTH+TEO in Saint Louis District only

Richard TollPétéPodorSaint Louis

SédhiouBounkiling IVM+ALBGoudomp IVM+ALBSédhiou IVM+ALB

Tambacounda

Bakel

(OMVS/PGIRE)

KidiraGoudiryDianké MakhaKoumpentoumTambacoundaMakacolibantang

Thiès Joal IVM+ALB X Xb

Mbour IVM+ALB Xb

Popenguine IVM+ALB Xb

Thiadiaye IVM+ALB X Xb

Pout IVM+ALBThiès IVM+ALBKhombole IVM+ALB+PZQ

Pending, based on FY16




survey



survey

mapping results: ZTH+TEO

Tivaouane

IVM+ALB


Mékhé

ALB


Ziguinchor

Diouloulou IVM+ALB XBignona IVM+ALB+PZQThionk Esyl IVM+ALB XOussouye IVM+ALB+PZQZiguinchor IVM+ALB X

aFor trachoma MDA, this will depend on the results of the impact surveys and subdistrict-level mapping surveys conducted in FY16.bFor budgetary reasons, just two of the eight districts that registered 5-9.9% TF in baseline mapping more than three years prior and have not initiated MDA, will conduct TIS in FY17. As this was a late development, the choice of districts to prioritize is still under discussion, so all eight districts remain listed here. The six districts that do not conduct their surveys in FY17, will do so in Q1 of FY18, still in line with the PNPSO target period of CY2017 for completion of the surveys.


· web viewsenegal work plan. fy 201. 7. project year . 6. october 201. 6 ‒ september 201....

Documents